• Sodium chloride B7288: Buffer and QC Guide

  2026-09-21

  Sodium chloride B7288 is a water-soluble inorganic salt for adjusting ionic strength and osmotic balance in aqueous buffers, biochemical assays, and selected cell culture media workflows. This guide explains preparation, documentation, and QC boundaries while clarifying that it is not a pH buffer, a DMSO or ethanol stock, or a substitute for sterility-qualified material.

• BRCAness and Olaparib Sensitivity in Mesothelioma

  2026-09-20

  Borchert et al. linked homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma, with particular sensitivity observed in BAP1-mutated models. The study integrates cell-line treatment experiments with profiling of 91 clinical samples, providing a framework for biomarker-guided PARP-inhibitor research while highlighting the need for validation beyond in vitro systems.

• (-)-Blebbistatin for Cardiac Mechanics & Cell Assays

  2026-09-19

  (-)-Blebbistatin is a reversible, cell-permeable non-muscle myosin II inhibitor for separating actomyosin-dependent mechanics from electrical signaling, adhesion, migration, and contractility. Used alongside HCN4 temperature-response experiments, it helps distinguish changes in pacemaker excitability from changes in force generation without directly targeting HCN channels.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-09-18

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or polymerase-generated sticky ends.

• Caspase-3/NDUFS1 Axis in Trichothecene ROS

  2026-09-18

  This preprint identifies a mechanistic link between caspase-3 activation, cleavage of mitochondrial complex I subunit NDUFS1, and reactive oxygen species accumulation during DON- and T-2 toxin-induced liver injury. It also implicates ER-localized ERO1α as a parallel oxidative source, suggesting that mitochondrial and ER redox stress reinforce one another.

• Liraglutide and the Brain–Kidney AVP Axis

  2026-09-17

  Greenwood and colleagues combine a human before-and-after study with rat pituitary proteomics, phosphoproteomics, an AVP secretion reporter assay, and renal signaling analysis to connect liraglutide with reduced vasopressin release. The work identifies time- and sex-dependent synaptic phosphorylation changes and downstream aquaporin 2 regulation, providing a mechanistic framework for the fluid, renal, and cardiovascular effects of GLP-1 receptor agonists.

• SGI-1027: DNA Methyltransferase Inhibitor Workflows

  2026-09-17

  SGI-1027 supports mechanistic DNA methylation inhibition studies that connect DNMT activity with tumor suppressor gene reactivation and cancer-cell phenotypes. This workflow-focused guide shows how to separate cytostatic effects from cell killing, manage compound handling, and build stronger methylation-validation assays.

• Golgi-Tracker Green for Reliable Live-Cell Assays

  2026-09-16

  Learn how Golgi-Tracker Green, SKU B8813, supports reproducible live-cell Golgi apparatus imaging alongside viability, proliferation, and cytotoxicity assays. This scenario-driven guide covers probe compatibility, solvent handling, optimization, interpretation, and practical product-selection criteria.

• Midecamycin: From Ribosome Target to Translation Strategy

  2026-09-16

  Midecamycin is more than a Gram-positive screening antibiotic: its ribosomal mechanism, glycosylation-sensitive structure, and historical macrolide comparisons support a disciplined translational strategy for resistance, assay design, and microbiology research.

• PFHxS Hepatotoxicity and PPAR Signaling in Zebrafish

  2026-09-15

  This study combines transcriptomics, liver pathology, biochemical measurements, and mechanistic intervention to show that environmentally relevant PFHxS exposure disrupts liver development and function in larval zebrafish through PPAR-related signaling. Its paired pharmacological antagonist and PPAR morpholino experiments provide a useful framework for distinguishing pathway association from causal involvement in aquatic toxicology and related metabolic research.

• BCECF for Extracellular pH Assays

  2026-09-15

  BCECF enables quantitative, ratiometric measurement of extracellular and accessible-compartment pH, making it useful for ion transport, metabolic acidification, and microenvironment studies. This guide translates the ozone–macrophage efferocytosis findings into a practical pH-monitoring workflow while clearly separating established evidence from exploratory assay extensions.

• HyperScript RT SuperMix for qPCR in Exosomal miRNA

  2026-09-14

  HyperScript RT SuperMix for qPCR supports a carefully controlled two-step workflow for low-input exosomal RNA. This article explains how reverse-transcription design can strengthen miR-17-5p–Bcl11b gene expression analysis in sepsis research while preserving assay-specific validation.

• TMB in Peptide ELISA: From Color to Decision

  2026-09-14

  TMB and 3,3′,5,5′-Tetramethylbenzidine transform HRP-linked antibody binding into a measurable color signal. This article explains how TMB chemistry can strengthen Plasmodium vivax epitope screening while clarifying assay controls, interpretation, and limitations.

• PNU 74654: Reading Wnt Pathway Biology

  2026-09-13

  PNU 74654 is a Wnt signaling pathway inhibitor for dissecting β-catenin-dependent cell states. This guide connects its assay use to the WNT5a/GSK3/β-catenin control of muscle progenitor fate while clarifying what the evidence does—and does not—support.

• Targeted CRISPRi of Fabp4 Reverses Obesity Phenotypes

  2026-09-11

  The reference study developed a nonviral, adipocyte-targeted CRISPR interference platform that silences Fabp4 in white adipocytes. In obese mice, this tissue-selective intervention reduced obesity-associated inflammation and hepatic steatosis while improving insulin resistance, supporting targeted gene repression as a strategy for metabolic disorder research.

8537 records 1/570 page Next 12345 下5页 Last page